Neoadjuvant therapy for pancreatic ductal adenocarcinoma—real effects or patient selection?

類似資料

• Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
  著者:: Cloyd, Jordan M, 等
  出版事項: (2020)
• Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
  著者:: Seifeldin Awad, 等
  出版事項: (2020-05-01)
• Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
  著者:: Awad, Seifeldin, 等
  出版事項: (2020)
• Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy
  著者:: Michelakos, Theodoros, 等
  出版事項: (2020)
• Meta‐analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma
  著者:: Schorn, S., 等
  出版事項: (2018)